Newsroom
August 14, 2023
Sudha Seshadri, MD, Neurology and founding director, The Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health San Antonio, was featured in this article. Read More
August 11, 2023
Sudha Seshadri, MD, Neurology and founding director, The Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health San Antonio, and Claudia Satizabal, PhD, Population Health Sciences and the Glenn Biggs Institute, were quoted in this story. Read More
July 30, 2023
Sudha Seshadri, MD, Neurology and founding director, The Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health San Antonio, was featured in this story. Read More
July 27, 2023
Volunteers 50 to 89 with a diagnosis of mild cognitive impairment or probable mild AD may ask about eligibility to participate in VIVA-MIND, a study to learn whether a new drug therapy for Alzheimer’s disease can help people experiencing mild memory problems.
July 27, 2023
Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu SAN ANTONIO (July 27, 2023) — The Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at The University of Texas Health Science Center at San Antonio is recruiting participants for VIVA-MIND, a study to learn whether a new drug therapy for Alzheimer’s disease (AD) can help people experiencing mild memory […]
July 25, 2023
Novel AI algorithm precisely counts lesions that signal risk of stroke.
